ASXL1 mutations define a subgroup of patients with acute myeloid leukemia with distinct gene expression profile and poor prognosis: a meta-analysis of 3311 adult patients with acute myeloid leukemia

Shivarov Velizar; Gueorguieva Ralitza; Ivanova Milena; Tiu Ramon V.

首页> 外文期刊>Leukemia and lymphoma >ASXL1 mutations define a subgroup of patients with acute myeloid leukemia with distinct gene expression profile and poor prognosis: a meta-analysis of 3311 adult patients with acute myeloid leukemia

【24h】

ASXL1 mutations define a subgroup of patients with acute myeloid leukemia with distinct gene expression profile and poor prognosis: a meta-analysis of 3311 adult patients with acute myeloid leukemia

机译：ASXL1突变定义了具有明显基因表达谱和预后不良的急性髓细胞性白血病患者亚组：一项对3311例急性髓性白血病成年患者的荟萃分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Leukemia and lymphoma》 |2015年第6期|共3页
作者
Shivarov Velizar; Gueorguieva Ralitza; Ivanova Milena; Tiu Ramon V.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 77例老年急性髓性白血病患者的预后因素分析 [J] . 邵彬, 赵初娴, 高彦荣, 癌症（英文版） . 2006,第008期
2. ASXL1 mutations define a subgroup of patients with acute myeloid leukemia with distinct gene expression profile and poor prognosis: a meta-analysis of 3311 adult patients with acute myeloid leukemia [J] . Shivarov Velizar, Gueorguieva Ralitza, Ivanova Milena, Leukemia and lymphoma . 2015,第6期

机译：ASXL1突变定义了具有明显基因表达谱和预后不良的急性髓细胞性白血病患者亚组：一项对3311例急性髓性白血病成年患者的荟萃分析
3. Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patients [J] . W-C Chou, C-Y Chen, H-A Hou, Leukemia . 2009,第7期

机译：携带t（7; 11）（p15; p15）的急性髓细胞性白血病是一个独特的细胞遗传学实体，其结局较差且具有明显的突变特征：对493名成人患者的比较分析
4. RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and microRNA expression signatures [J] . MendlerJ.H., MaharryK., RadmacherM.D., Journal of Clinical Oncology . 2012,第25期

机译：RUNX1突变与细胞遗传学正常的急性髓性白血病的年轻和老年患者的不良结局有关，并具有独特的基因和microRNA表达特征
5. A BLSTM with Attention Network for Predicting Acute Myeloid Leukemia Patient’s Prognosis using Comprehensive Clinical Parameters [C] . Chih-Chuan Lu, Jeng-Lin Li, Yu-Fen Wang, . 2019

机译：带有注意力网络的BLSTM，可使用综合的临床参数预测急性髓性白血病患者的预后
6. Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study [D] . Harada Yasuhiko, 原田靖彦 2019

机译：根据2017年日本成人白血病研究组（JALSG）AML201研究治疗的成人急性髓性白血病患者的遗传学预测，根据2017 ELN风险分层进行预后分析
7. ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study Group [O] . Peter Paschka, Richard F. Schlenk, Verena I. Gaidzik, 2015

机译：年轻的急性髓样白血病患者的ASXL1突变：德国-奥地利急性髓样白血病研究组的一项研究
8. Identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemia. [O] . Yiming Tian, Zoufang Huang, Zhixiang Wang, 2014

机译：鉴定新的分子标志物用于评估急性髓性白血病的预后：pDCD7，FIs1和ang2的过度表达可能预示着治疗急性髓性白血病的患者预后不良。

ASXL1 mutations define a subgroup of patients with acute myeloid leukemia with distinct gene expression profile and poor prognosis: a meta-analysis of 3311 adult patients with acute myeloid leukemia

著录项

相似文献

相关主题

期刊订阅